Schroders Capital to scale beyond $1 bn India bet, eyes consumer and healthcare deals
After deploying ~$1 billion over a decade across names like Lenskart, PineLabs and Giva, Schroders Capital is doubling down on India with $50 million average tickets in consumer, healthcare, tech and AI — leaning on secondaries and continuation vehicles as exit routes broaden beyond IPOs.
Schroders Capital plans to ramp up India investments after deploying ~$1 billion over a decade, targeting consumer, healthcare, tech and AI sectors, with growing focus on secondaries and continuation vehicles as exit routes beyond IPOs.